Clinical Trial

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A single-center, single-arm, dose-escalation exploratory clinical trial on the safety, efficacy, and pharmacokinetics of R-Star001 cell injection in patients with Nectin-4-positive advanced solid tumors.
Trial Details
NCT Number NCT07101549
Lead Sponsor changjianhua
Conditions Advanced Solid Tumors
Enrollment 25 participants
Start Date 2025-08-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-03